ALB Q4 Earnings Miss, Revenues Beat on Higher Volumes & Pricing

Core Insights - Albemarle Corporation (ALB) reported an adjusted loss of 53 cents per share in Q4 2025, compared to a loss of $1.09 per share a year ago, which was wider than the Zacks Consensus Estimate of a loss of 40 cents [1] Revenue Performance - Revenues increased by approximately 15.9% year over year to $1,428 million in the quarter, surpassing the Zacks Consensus Estimate of $1,349.8 million, driven by higher volumes in Energy Storage and Ketjen, as well as increased pricing in Energy Storage [2] - Adjusted EBITDA for the quarter was $268.7 million, up from $250.7 million in the prior-year quarter, fueled by higher pricing in Energy Storage and increased volumes in Ketjen [2] Segment Highlights - Sales from the Energy Storage unit rose around 23.1% year over year to $759.1 million, exceeding the consensus estimate of $717 million, attributed to higher volumes and pricing [3] - The Specialties segment recorded sales of $348.9 million, up around 4.8% year over year, in line with the consensus estimate, benefiting from higher volumes and pricing [3] - The Ketjen unit generated revenues of $320.1 million, up roughly 13.5% year over year, beating the consensus estimate of $296 million, driven by higher fluidized catalytic cracking volumes and timing of Clean Fuels technology [4] Financial Position - Albemarle ended the quarter with cash and cash equivalents of approximately $1,618 million, an increase from $1,192.2 million reported in the prior-year quarter, while long-term debt remained around $3,119.5 million [5] - Cash from operations for the year ended December 31, 2025, was around $1.3 billion, reflecting an 85% increase from the prior-year period [5] 2026 Outlook - Albemarle anticipates energy storage sales volumes to be roughly flat in 2026 following inventory drawdowns in 2025, with modest volume growth expected in the Specialties segment, projecting net sales to be flat to down year over year [6] - The sale of the Ketjen unit is expected to close in the first quarter of 2026 [6] Expenses Forecast - Depreciation and amortization expenses are expected to be between $660 million and $680 million for 2026, with capital expenditures projected at $550 million to $600 million, and interest and financing expenses forecasted at $150 million to $170 million for the full year [7] Stock Performance - Albemarle's shares have increased by 116.5% over the past year, contrasting with a 11.9% decline in the Zacks Chemicals Diversified industry [8]